Biofrontera Inc. (BFRIW) stock
BFRIWNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as BFRI
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026Score 10/30
$0.00+0.00 (0.00%)
Close on Oct 30, 2026Market cap $12.96MP/E –Yield –
Biofrontera total assets
Total assets on the balance sheet at the end of each period.
Biofrontera's total assets was $24.06M at Jun 30, 2026. For fiscal 2025 it was $28.56M, up 29.2% from the year before. The highest annual figure on record is $53.22M in fiscal 2021.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $28.56M | +29.2% |
| FY2024 | Dec 31, 2024 | $22.10M | -20.9% |
| FY2023 | Dec 31, 2023 | $27.93M | -45.1% |
| FY2022 | Dec 31, 2022 | $50.88M | -4.4% |
| FY2021 | Dec 31, 2021 | $53.22M | +120.5% |
| FY2020 | Dec 31, 2020 | $24.14M | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $24.06M | +19.5% |
| Q1 FY2026 | Mar 31, 2026 | $24.79M | +49.4% |
| Q4 FY2025 | Dec 31, 2025 | $28.56M | +29.2% |
| Q3 FY2025 | Sep 30, 2025 | $15.42M | -16.7% |
| Q2 FY2025 | Jun 30, 2025 | $20.14M | -6.6% |
| Q1 FY2025 | Mar 31, 2025 | $16.59M | -32.5% |
| Q4 FY2024 | Dec 31, 2024 | $22.10M | -20.9% |
| Q3 FY2024 | Sep 30, 2024 | $18.52M | -45.7% |
| Q2 FY2024 | Jun 30, 2024 | $21.57M | -41.5% |
| Q1 FY2024 | Mar 31, 2024 | $24.58M | -41.4% |
| Q4 FY2023 | Dec 31, 2023 | $27.93M | -45.1% |
| Q3 FY2023 | Sep 30, 2023 | $34.10M | -38.1% |
| Q2 FY2023 | Jun 30, 2023 | $36.91M | -31.2% |
| Q1 FY2023 | Mar 31, 2023 | $41.97M | -14.7% |
| Q4 FY2022 | Dec 31, 2022 | $50.88M | -4.4% |
| Q3 FY2022 | Sep 30, 2022 | $55.06M | +258.6% |
| Q2 FY2022 | Jun 30, 2022 | $53.63M | +122.2% |
| Q1 FY2022 | Mar 31, 2022 | $49.20M | – |
| Q4 FY2021 | Dec 31, 2021 | $53.22M | – |
| Q3 FY2021 | Sep 30, 2021 | $15.35M | – |
| Q4 FY2020 | Dec 31, 2020 | $24.14M | – |